C arotid endarterectomy has been proven to reduce the incidence of ipsilateral strokes in patients with symptomatic and asymptomatic carotid stenoses Ն70%. [1] [2] [3] On average, however, 2% to 6% of all patients undergoing carotid endarterectomy sustain a stroke in the perioperative period. 4 Intraoperative embolism and hypoperfusion are possible causes of a perioperative neurological deficit due to clamping of the carotid artery.
Two major hypotheses have been developed to account for the phenomenon of ischemia/reperfusion-induced neuronal death. The neurotransmitter hypothesis is related to the role of excitotoxic amino acids and is preferentially aimed at events during the acute period of ischemia. The free radical hypothesis is directed at events during reperfusion. 5 The generation of reactive oxygen species (ROS) initiates a vicious cascade of tissue injury. In particular, ROS lead to peroxidation of phospholipids with consecutive alteration of membrane structure. These events provide a conceptual basis to explain delayed neuronal death after periods of ischemia/reperfusion. 6 In animal studies it has been shown that endothelial adhesion of polymorphonuclear leukocytes (PMN), which generate ROS and reactive nitrogen species, significantly contributes to the pathogenesis of reperfusion injury after focal ischemia. 7, 8 This clinical study investigates the interrelation between cerebral energy metabolism, nitric oxide (NO) metabolism, cellular activation, and cerebral lipid peroxidation as indicated by the formation of malondialdehyde (MDA) in patients undergoing carotid endarterectomy.
Focal cerebral ischemia was induced by acute vascular occlusion of the common carotid artery, and the extent of ischemia was verified by monitoring of somatosensory evoked potentials (SSEP). During carotid surgery a vascular shunt was placed only under conditions when total loss of SSEP amplitude occurred, indicating a regional cerebral blood flow Ͻ15 mL/min per 100 g. Carotid endarterectomy is a relevant clinical model to study focal cerebral ischemia/ reperfusion injury in patients.
Subjects and Methods
After institutional approval, informed consent was obtained from 25 patients (mean age, 65Ϯ2 years; age range, 40 to 82 years) undergoing elective carotid endarterectomy. The group included 6 women and 19 men. In all but 5 patients without prior symptoms, the indication for carotid endarterectomy was symptomatic carotid artery stenosis Ն70%. Thirteen patients took aspirin as antiplatelet medication, whereas none of the patients took antioxidants. After premedication with midazolam (3.75 to 7.5 mg), anesthesia was induced with 1 to 3 mg midazolam, 2 to 5 g ⅐ kg Ϫ1 fentanyl, 0.15 to 0.3 mg ⅐ kg Ϫ1 etomidate, and 0.5 mg ⅐ kg Ϫ1 atracurium. After intubation, anesthesia was maintained with nitrous oxide in oxygen (N 2 O:O 2 ϭ50:50) and 0.2% to 0.6% isoflurane. Atracurium and fentanyl were administered intraoperatively as necessary. All patients were mechanically ventilated to maintain normocapnia with PaCO 2 of 38 to 41 mm Hg. In each patient, ECG, end-tidal capnometry, and arterial blood pressure changes were continuously recorded. A thorough neurological examination was performed immediately after the patient awakened, 1 hour later, and then daily until the patients were discharged.
Intraoperatively, SSEP were continuously recorded after contralateral median nerve stimulation (Nicolet Spirit) to detect critical regional hypoperfusion due to carotid cross-clamping. Importantly, a shunt was placed only after complete loss of the N20/P25 SSEP amplitude. According to this criterion, intraoperative shunting of the carotid artery was performed in 5 of 25 patients (shunt group [nϭ5] versus no-shunt group [nϭ20], respectively). In addition, a catheter was placed intraoperatively into the ipsilateral jugular bulb by the surgeon to obtain jugular venous blood samples. The correct catheter position in the jugular bulb was verified by intraoperative angiography. Heparin (5000 U) was given intravenously to all patients before carotid cross-clamping, and hydroxyethyl starch (500 mL) was regularly infused. Arterial and jugular venous blood samples were collected regularly before carotid cross-clamping, 10 minutes after carotid artery occlusion, before reperfusion, and 15 minutes after reperfusion, respectively. In patients with shunt, however, the end of shunt placement (6Ϯ1 minutes) was taken as the start of the reperfusion period.
Soluble P-selectin (sP-selectin) and soluble L-selectin (sLselectin) were measured by enzyme-linked immunosorbent assays (Bender MedSystems). Plasma nitrite/nitrate was assayed by the Griess reaction 9 with a commercially available kit (Boehringer Mannheim). Plasma total antioxidant status was determined spectrophotometrically (Randox). We measured MDA by high-performance liquid chromatography (HPLC) using a slight modification of the method of Lepage et al. 10 First 250 L of distilled water and 10 L of 0.5% butylated hydroxytoluene were added to 250 L plasma in a glass tube. This was followed by the addition of 200 L of 0.66N H 2 SO 4 and 150 L of 0.3 mol/L Na 2 WO 4 . Thereafter, the mixture was centrifuged at 1000g for 10 minutes. Next 500 L of the supernatant was mixed with 167 L of 50 mmol/L thiobarbituric acid solution. The mixture was then heated at 100°C for 60 minutes. Twenty microliters of this reaction solution was then used for HPLC analysis with a Hypersil ODS C-18 column with 5-m particle size. The mobile phase consisted of methanol and water in a gradient mode. After an initial period of 2 minutes with water alone, the methanol/water gradient was changed from 0% to 50% over a 2-minute period with a hold at that mixture for 6.5 minutes. Finally, the gradient was reversed to 100% water within 5 minutes. After 11.5 minutes of reequilibration at that level, the next sample was injected. The flow rate was 0.45 mL/min, and the column eluate was detected by UV spectrophotometry (Merck) at 532 nm. Purine compounds were determined as previously described. 11 In brief, blood samples (1 mL) were collected in precooled dipyridamole solution (1 mL, 5ϫ10
Ϫ5 mol/L) to prevent nucleoside uptake by red blood cells. After immediate centrifugation at 4°C, plasma supernatant (1 mL) was deproteinated with perchloric acid (70%, 0.1 mL). After neutralization (KH 2 PO 4 ) and centrifugation, nucleosides were determined by HPLC. Samples (0.1 mL) were automatically injected onto a C-18 column (Nova-Pak C18, 3.9ϫ150 mm, Waters). The linear gradient started with 100% KH 2 PO 4 (0.001 mol/L, pH 4.0) and increased to 60% of 60/40 methanol/water (vol/vol) in 15 minutes, the flow rate being 1.0 mL/min. This was followed by a reversal of the gradient to initial conditions over the next 3 minutes. Absorbance of the column eluate was simultaneously monitored at 254 nm for adenosine and hypoxanthine, respectively, and at 293 nm for uric acid with photodiode array detection (Waters). Purine compounds were quantified with a computer-assisted program (Millenium, Waters).
Statistical Analysis
Results are expressed as meanϮSEM. Differences within or between the patient groups were examined by ANOVA followed by Scheffé multiple comparisons. Statistical significance is at the PՅ0.05 level.
Results
In the present study a total loss of SSEP amplitude occurred in 5 patients at 6Ϯ1 minutes after carotid artery occlusion. Therefore, intraoperative shunt placement was performed in 5 of 25 patients (shunt group [nϭ5] versus no-shunt group [nϭ20], respectively). As can be seen in Table 1 , no significant differences between the groups were obtained in hemodynamic parameters, PaO 2 , PaCO 2 , or hemoglobin concentrations throughout the study period. In patients in the shunt group, SSEP amplitude remained depressed at 15 minutes after reperfusion despite reperfusion (Table 2) . One patient in the shunt group suffered postoperatively from a transient neurological deficit. It is important to note that the mean occlusion time in the no-shunt group was 30Ϯ2 minutes, which was significantly longer than that in the shunt group (6Ϯ1 minutes). In patients in the shunt group, shunt opening was taken as the start of reperfusion.
Under baseline conditions, there was no significant difference in jugular venous-arterial lactate concentration difference (⌬LAC) between the shunt group and the no-shunt group (Table 2 ). In patients with inadequate collateral blood flow (shunt group), however, ⌬LAC was significantly increased during carotid artery occlusion and remained elevated until 15 minutes after reperfusion.
Before carotid artery occlusion, no significant difference in jugular venous-arterial adenosine difference (⌬ADO) was obtained between the groups. Major concentration changes of adenosine across the cerebral vascular bed were observed during the clamping period, when ⌬ADO exhibited a peak value of 181Ϯ37 nmol/L at 6 minutes after carotid crossclamping. In contrast to lactate, ⌬ADO returned to control levels within 15 minutes after reperfusion. In general, similar results were also obtained in the case of hypoxanthine and nitrite/nitrate in the shunt group.
Under baseline conditions, the jugular venous-arterial difference in plasma total antioxidant status (⌬TAS) was higher in patients with inadequate collateral blood flow (shunt group). While ⌬TAS remained nearly unchanged in the no-shunt group, carotid artery clamping induced a significant decrease in ⌬TAS in the shunt group.
In patients with adequate collateral blood flow (no-shunt group), jugular venous-arterial MDA concentration differences (⌬MDA) remained almost stable throughout the study period (Figure) . In patients with inadequate collateral blood flow (shunt group), ⌬MDA and jugular venous-arterial concentration difference in sP-selectin (⌬sP-selectin) were significantly different from those in patients with adequate collateral blood flow under control conditions. Furthermore, in the shunt group significant changes in ⌬MDA also occurred after cross-clamping of the carotid artery. ⌬MDA increased from baseline values (34Ϯ26 nmol/L) to 130Ϯ49 nmol/L at the end of the occlusion period (6Ϯ1 minutes). At 15 minutes of reperfusion, there was an additional rise of ⌬MDA to 291.0Ϯ70.9 nmol/L (PՅ0.05).
Both ⌬sP-selectin and jugular venous-arterial concentration difference in Sl-selectin (⌬sL-selectin) exhibited only minor changes throughout the study period in patients with sufficient collateral perfusion (no-shunt group). Despite a significantly shorter period of vessel occlusion in the shunt group, ⌬sP-selectin was enhanced in parallel with the changes in MDA during carotid occlusion and reperfusion, respectively. In contrast, ⌬sL-selectin exhibited significant changes only at the end of the study period (15 minutes after reperfusion).
Discussion
In patients undergoing carotid endarterectomy, the jugular venous-arterial MDA concentration differences (⌬MDA) were significantly higher in patients in whom a total loss of SSEP amplitude occurred (shunt group). In contrast to patients with adequate collateral blood flow (no-shunt group), increased ⌬MDA was obtained during an occlusion period as short as 6Ϯ1 minutes and exhibited a 6-fold increase at 15 minutes after start of reperfusion.
ROS such as superoxide anions (O 2 •Ϫ ), hydrogen peroxides (H 2 O 2 ), and the extremely toxic hydroxyl radical (⅐OH) are difficult to detect in patients because of their short half-life. Therefore, byproducts of lipid peroxidation or depletion of endogenous antioxidants have often been used as indirect markers for free radical generation. [12] [13] [14] MDA is a 3-carbon compound, which reflects both auto-oxidation and oxygen radical-mediated peroxidation of polyunsaturated fatty acids, in particular, arachidonic acid. 14, 15 However, release of MDA is not specific for lipid peroxidation, because other sources of MDA formation have been described. In certain tissues, MDA can also be formed by nonenzymatic or enzymatic processes, for example, by human platelet synthetase. [15] [16] [17] Nevertheless, the significant increase in ⌬MDA in the shunt group together with the decrease in ⌬TAS across the cerebral circulation is a strong indication that lipid peroxidation takes place in the cerebral vascular bed even after short periods of incomplete cerebral ischemia. This is even more evident because the obtained changes in ⌬TAS are temporally related to the occurrence of cerebral ischemia. 14, 18, 19 Clinically, the occurrence of short-term incomplete cerebral ischemia in the shunt group was verified by total loss of SSEP amplitude after carotid cross-clamping. The electrophysiological changes indicate a local cerebral blood flow Ͻ15 mL/min per 100 g and are associated with a significant impairment of cellular ion homeostasis. 20, 21 In addition, the significant increases in ⌬LAC and ⌬ADO are further evidence that some degree of cerebral ischemia is present in patients with a shunt during carotid artery occlusion. In particular, adenosine has been characterized as a sensitive indicator of disturbances in tissue oxygenation in several organs, including the brain. 22, 23 The data indicate that metabolic parameters are altered in close parallelism with the impairment of cerebral function (SSEP) when inadequate collateral blood flow is present in patients undergoing carotid endarterectomy. In patients with shunt, the shunt was placed to restore cerebral perfusion and to avoid neuronal death due to ischemia. Since shunt placement was completed at 6Ϯ1 minutes after carotid cross-clamping, it is of particular interest that the changes in cerebral lipid peroxidation were also induced after a relatively short period of focal cerebral ischemia followed by reperfusion.
Enhanced generation of ROS in the postischemic reperfusion period induces oxidative damage of proteins and lipids 24 and impairs mitochondrial function. 25 In animal experiments with 2 hours of middle cerebral artery occlusion, both mitochondrial function and the bioenergetic cellular state were shown to only partially recover in the first hour after reperfusion and to deteriorate again within 2 to 4 hours after reperfusion. Folbergrová et al 6 are causally involved in the impairment of cellular energy metabolism because the spin-trapping agent N-tert-butyl-␣-phenylnitrone (PBN) improved mitochondrial function and reduced infarct volume. The changes in lactate give additional indirect evidence that impaired cellular energy metabolism occurred under conditions of short-term carotid occlusion. In contrast to adenosine, ⌬LAC remained enhanced in patients with shunt at 15 minutes after reperfusion. This ongoing lactate production by the brain could be due to ROS-dependent postischemic inhibition of the pyruvate dehydrogenase complex, which reflects impaired mitochondrial function. 26 This hypothesis is further supported by clinical data demonstrating that the electrophysiological function of these patients was still depressed at 15 minutes after reperfusion, as indicated by changes in SSEP.
Few data have been presented concerning oxidant production during cerebral ischemia and reperfusion in patients. While Soong et al 19 found an increase in jugular venous MDA only 60 seconds after carotid clamp removal, Bacon et al 12 observed a decrease in the antioxidant capacity across the cerebral circulation after declamping of the external and internal carotid arteries. In contrast to our study, focal cerebral ischemia was documented in neither of the mentioned investigations, because a shunt was either generally inserted in all patients 19 or none of the subjects required a shunt. 12 In the present study the origin of MDA formation in the shunt group is difficult to determine. For instance, brain tissue itself is at particular risk of being injured by oxidantmediated triggers because tissue contains large iron stores and high levels of polyunsaturated lipids but exhibits only poor antioxidant defenses. In addition, the cerebral vascular endothelium can also be one source for the rise in MDA. Interestingly, ⌬MDA in the shunt group was already elevated at the end of the ischemic period. This finding demonstrates that molecular events leading to oxygen radical production not only occur during reperfusion but also during short-term and incomplete tissue ischemia.
Biochemically, a potential source of ROS formation is purine catabolism. During ischemia, accumulation of adenosine and its metabolite hypoxanthine (see Table 2 ) takes place. While in the normoxic brain hypoxanthine is metabolized by xanthine dehydrogenase to xanthine and ultimately to uric acid, the enzyme xanthine dehydrogenase is converted to xanthine oxidase during ischemia. In contrast to xanthine dehydrogenase, xanthine oxidase instead uses molecular oxygen of the nucleotide radical of NAD ϩ as its electron acceptor, thereby catalyzing the formation of O 2
•Ϫ during reperfusion. 5, 27 Xia and Zweier 28 have demonstrated that the free radical formation via xanthine oxidase is substrate driven. Because adenosine and hypoxanthine accumulate significantly in patients with shunt before reperfusion, the substrate-dependent conversion of hypoxanthine/xanthine to uric acid by xanthine oxidase seems to be an important source for the initial burst of free radical generation. Interestingly, this is coincident with a simultaneous decrease in plasma total antioxidant status.
Another important source of ROS is the metabolism of NO. NO reacts with superoxide to yield the peroxynitrite anion (ONOO Ϫ ), which decomposes to ⅐OH. 29 Furthermore, the peroxynitrite anion itself is also a highly reactive oxidizing agent that can cause tissue damage. 8 Experimental studies have demonstrated that NO mediates glutamate neurotoxicity in primary cortical cultures 30 and that inhibition of NO generation can reduce infarct volume induced by transient occlusion of the middle cerebral artery. 31 In this clinical study the ratio of nitrite/nitrate was taken as an indirect marker of NO production. 9 Interestingly, in this clinical study the ratio of nitrite/nitrate was actually increased in the shunt group. Moreover, these results were well matched with the decrease in plasma total antioxidant status before reperfusion. Therefore, the observed changes can be taken as indirect evidence that NO metabolism might contribute to ROS generation in patients undergoing carotid endarterectomy.
del Zoppo et al 32 suggested a pivotal role for PMN in cerebral ischemia. This hypothesis is supported by the finding that antibodies to PMN or adhesion molecules ameliorate infarct volume after transient ischemia in animals. 33, 34 In addition, Okada et al 35 have shown in baboon experiments that P-selectins can be detected on the cerebral endothelium in the early phase of reperfusion after cerebral artery occlusion. Until now, however, no data have been available concerning the kinetics of adhesion molecule expression during short-term ischemia/reperfusion in patients. In this study we measured ⌬sP-selectin and ⌬sL-selectin to characterize the changes in cerebral expression and shedding of both adhesion molecules.
Similar to the changes in ⌬MDA, we found a significant increase in ⌬sP-selectin in the shunt group before reperfusion, indicating enhanced expression and shedding of P-selectin. In contrast, at this point ⌬sL-selectin was nearly unchanged. P-selectin expression, which is observed within minutes after endothelial activation, increases the number of PMN rolling along the endothelium. 36 Rolling brings PMN into close proximity to chemoattractants such as plateletactivating factor, which is also expressed on endothelial cells in response to ROS. 37 As a result, strong attachment of PMN to the endothelium occurs. The marked elevation of ⌬sL-selectin in the shunt group at 15 minutes after reperfusion provides indirect evidence that activation of PMN is likely to take place within the cerebral vascular bed.
In conclusion, we demonstrate that lipid peroxidation can occur during short-term and incomplete cerebral ischemia/ reperfusion in patients undergoing carotid endarterectomy. Although the quantitative role of each compartment cannot be determined as yet, the data demonstrate that the ATPdegradation pathway, NO metabolism, as well as cellular factors such as PMN are likely to contribute to the production of ROS under conditions of cerebral ischemia/reperfusion.
